- Home
- ASND vs EMBJ Comparison
ASND vs EMBJ Comparison
Compare ASND & EMBJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | EMBJ |
|---|---|---|
| Founded | 2006 | 1969 |
| Country | Denmark | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 12.9B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASND | EMBJ |
|---|---|---|
| Price | $232.30 | $72.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $277.13 | N/A |
| AVG Volume (30 Days) | 694.9K | ★ 790.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $98.99 | N/A |
| Revenue Next Year | $41.45 | $14.36 |
| P/E Ratio | ★ N/A | $159.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $124.06 | $59.73 |
| 52 Week High | $242.00 | $80.75 |
Technical Indicators
Market Signals| Indicator | ASND | EMBJ |
|---|---|---|
| Relative Strength Index (RSI) | 57.40 | 50.16 |
| Support Level | $190.49 | $68.91 |
| Resistance Level | $242.00 | $74.85 |
| Average True Range (ATR) | 9.59 | 1.87 |
| MACD | 0.44 | -0.12 |
| Stochastic Oscillator | 81.29 | 50.39 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About EMBJ Embraer S.A.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.